Brokerages Set Agilent Technologies, Inc. (NYSE:A) Target Price at $159.35

Agilent Technologies, Inc. (NYSE:A) has earned an average recommendation of “Moderate Buy” from the nineteen ratings firms that are presently covering the firm, Marketbeat reports. Four research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. The average 1 year target price among analysts that have covered the stock in the last year is $160.2353.

A has been the subject of several recent analyst reports. Morgan Stanley raised their target price on shares of Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a research note on Wednesday. Barclays upped their price objective on Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a research note on Wednesday, June 24th. Royal Bank Of Canada assumed coverage on Agilent Technologies in a research report on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 price objective for the company. Weiss Ratings upgraded Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Finally, TD Cowen boosted their target price on Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, May 28th.

Hedge Funds Weigh In On Agilent Technologies

Several large investors have recently modified their holdings of the stock. Norges Bank acquired a new stake in shares of Agilent Technologies during the 4th quarter worth about $549,158,000. Bank of New York Mellon Corp grew its stake in Agilent Technologies by 87.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock valued at $695,227,000 after buying an additional 2,440,360 shares during the last quarter. Massachusetts Financial Services Co. MA raised its holdings in Agilent Technologies by 13.8% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after acquiring an additional 1,713,216 shares during the period. AQR Capital Management LLC raised its holdings in Agilent Technologies by 424.1% in the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after acquiring an additional 1,652,244 shares during the period. Finally, Ameriprise Financial Inc. lifted its position in Agilent Technologies by 132.2% during the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after acquiring an additional 1,340,161 shares during the last quarter.

Agilent Technologies Price Performance

Shares of A opened at $149.33 on Friday. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The company’s fifty day simple moving average is $135.12 and its 200 day simple moving average is $125.40. Agilent Technologies has a 1-year low of $108.35 and a 1-year high of $160.27. The company has a market cap of $42.18 billion, a price-to-earnings ratio of 29.99, a PEG ratio of 2.62 and a beta of 1.25.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The firm had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. During the same quarter last year, the company posted $1.31 earnings per share. The company’s revenue for the quarter was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, research analysts forecast that Agilent Technologies will post 6.03 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were given a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, June 30th. Agilent Technologies’s payout ratio is 20.48%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.